Dr. Morgan Taylor, M.D.
What this data tells you about Dr. Taylor
Dr. Morgan Taylor is a gynecologic oncology physician in Detroit, MI, with 18 years of NPI registration. Based on federal Medicare data, Dr. Taylor performed 5,186 Medicare services across 265 unique beneficiaries.
Between the years covered by Open Payments, Dr. Taylor received a total of $23,232 from 43 pharmaceutical and/or device companies across 226 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gynecologic oncology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Taylor is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,900 | $0 | $7 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,550 | $1 | $54 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
167 | $14 | $60 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
160 | $119 | $520 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
157 | $26 | $110 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
109 | $93 | $355 |
| New patient office visit, complex (60-74 min) | 54 | $164 | $570 |
| Pelvic and clinical breast exam for cancer screening A physical examination of the pelvis and breasts to screen for cervical or vaginal cancer. This procedure involves a clinical assessment performed by a healthcare provider. |
50 | $43 | $140 |
| Laparoscopic hysterectomy with salpingo-oophorectomy, 250g or less Surgical removal of the uterus, fallopian tubes, and/or ovaries through small abdominal incisions using a camera-guided instrument. The procedure is specified for cases where the removed tissue weighs 250 grams or less. |
14 | $453 | $2,649 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
14 | $68 | $300 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
11 | $33 | $670 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
All-time payments by company (2018-2024) ›
Associated products mentioned in payments ›
The majority of payments (66%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in gynecologic oncology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for gynecologic oncology physician in MI.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Taylor is a mixed practice specialist, with above-average Medicare volume (top 4% in MI), with speaking/promotional industry engagement in the top 6% of MI peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Taylor experienced with dexamethasone injection (steroid)?
Does Dr. Taylor receive payments from pharmaceutical companies?
How do Dr. Taylor's costs compare to other gynecologic oncology physicians in Detroit?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology